Back

Renal and hemodynamic effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction in DELIVER

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - pathophysiology 1 Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Safia Chatur

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

5 More presentations in this session

Presentation thumbnail
Cardiometabolic differences between patients with reduced and preserved ejection fraction: a proposal for phenotyping
Doctor N. Pugliese (Pisa, IT)
Abstract Slides
Presentation thumbnail
Association between visceral and epicardial adiposity in heart failure with mildly reduced and preserved ejection fraction: a CT and MRI based study.
Miss M. Lobeek (Groningen, NL)
Abstract Slides
Presentation thumbnail
Left ventricular diastolic dysfunction and its predictive factors in patients with type 2 diabetes mellitus
Doctor R. Aldhahi (Riyadh, SA)
Abstract Slides
Presentation thumbnail
Association between electrocardiographic diastolic index and left atrial dysfunction in heart failure with preserved ejection fraction
Associate Professor B. MURAT (Eskisehir, TR)
Abstract Slides
Presentation thumbnail
Thinking the other side of the coin: Which diastolic pressure should be used for assessing diastolic function?
Doctor D. Akaslan (Istanbul, TR)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - pathophysiology 1

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources